| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.939 | 0 | 0.939 | Transcortin receptor antagonist | 0.008 0.003 DBMET00598 | ||
| 0.94 | 0.002 | 0.94 | Androgen antagonist | 0.157 0.021 DBMET00598 | ||
| 0.913 | 0.005 | 0.913 | Antiinflammatory | 0.902 0.005 DBMET00598 0.9 0.005 DBMET00605 | ||
| 0.905 | 0.006 | 0.923 | Transcription factor NF kappa B inhibitor | 0.923 0.004 DBMET00598 0.891 0.007 DBMET00605 | DBMET00598 | |
| 0.859 | 0.002 | 0.859 | Anesthetic general | 0.672 0.004 DBMET00598 0.728 0.003 DBMET00605 | ||
| 0.816 | 0.003 | 0.816 | Hypoxia-inducible factor 1 alpha inhibitor | 0.519 0.013 DBMET00598 0.36 0.042 DBMET00605 | ||
| 0.761 | 0.002 | 0.761 | Aromatase inhibitor | |||
| 0.714 | 0.028 | 0.793 | Apoptosis agonist | 0.679 0.034 DBMET00598 0.793 0.017 DBMET00605 | DBMET00605 | |
| 0.673 | 0.004 | 0.673 | Diuretic | 0.525 0.006 DBMET00598 0.298 0.023 DBMET00605 | ||
| 0.668 | 0.01 | 0.862 | Cholesterol antagonist | 0.797 0.004 DBMET00598 0.862 0.003 DBMET00605 | DBMET00605 | |
| 0.626 | 0.001 | 0.626 | Aldosterone antagonist | 0.058 0.021 DBMET00598 | ||
| 0.63 | 0.01 | 0.63 | Immunosuppressant | 0.627 0.01 DBMET00598 0.62 0.011 DBMET00605 | ||
| 0.616 | 0.002 | 0.616 | Interferon gamma antagonist | 0.524 0.005 DBMET00598 0.401 0.011 DBMET00605 | ||
| 0.611 | 0.002 | 0.611 | Lipocortins synthesis antagonist | 0.408 0.008 DBMET00598 0.345 0.014 DBMET00605 | ||
| 0.623 | 0.033 | 0.706 | Caspase 9 stimulant | 0.51 0.056 DBMET00598 0.706 0.023 DBMET00605 | DBMET00605 | |
| 0.589 | 0.011 | 0.617 | Apoptosis antagonist | 0.617 0.008 DBMET00598 0.613 0.008 DBMET00605 | DBMET00598 | |
| 0.564 | 0.004 | 0.564 | Aldehyde dehydrogenase inhibitor | 0.239 0.02 DBMET00598 0.11 0.083 DBMET00605 | ||
| 0.558 | 0.002 | 0.558 | Mineralocorticoid receptor antagonist | 0.122 0.006 DBMET00598 0.053 0.027 DBMET00605 | ||
| 0.547 | 0.001 | 0.547 | Glucose-6-phosphate dehydrogenase inhibitor | 0.106 0.003 DBMET00598 0.136 0.002 DBMET00605 | ||
| 0.544 | 0.002 | 0.544 | Progesterone antagonist | |||
| 0.555 | 0.036 | 0.726 | Cyclophilin D inhibitor | 0.664 0.018 DBMET00598 0.726 0.012 DBMET00605 | DBMET00605 | |
| 0.53 | 0.032 | 0.53 | Antiobesity | 0.222 0.185 DBMET00605 | ||
| 0.474 | 0.005 | 0.474 | Sodium/bile acid cotransporter inhibitor | 0.371 0.028 DBMET00598 0.44 0.009 DBMET00605 | ||
| 0.464 | 0.005 | 0.464 | Antipruritic | |||
| 0.46 | 0.006 | 0.46 | NOS3 expression enhancer | 0.407 0.008 DBMET00598 0.291 0.019 DBMET00605 | ||
| 0.45 | 0.001 | 0.45 | Glucocorticoid agonist | 0.075 0.003 DBMET00598 0.049 0.004 DBMET00605 | ||
| 0.46 | 0.019 | 0.576 | Nitric oxide antagonist | 0.555 0.012 DBMET00598 0.576 0.011 DBMET00605 | DBMET00605 | |
| 0.441 | 0.012 | 0.441 | P-glycoprotein inhibitor | 0.247 0.042 DBMET00598 0.198 0.065 DBMET00605 | ||
| 0.425 | 0.004 | 0.425 | Estrogen receptor alpha antagonist | |||
| 0.418 | 0.002 | 0.418 | 5-Alpha-reductase inhibitor | 0.068 0.014 DBMET00598 | ||
| 0.445 | 0.041 | 0.445 | Aldehyde oxidase inhibitor | |||
| 0.4 | 0.002 | 0.4 | Androgen agonist | 0.062 0.039 DBMET00598 | ||
| 0.402 | 0.027 | 0.461 | Interleukin 2 agonist | 0.461 0.014 DBMET00598 0.393 0.029 DBMET00605 | DBMET00598 | |
| 0.368 | 0.001 | 0.368 | Arachidonic acid antagonist | 0.272 0.003 DBMET00598 0.225 0.014 DBMET00605 | ||
| 0.358 | 0.002 | 0.358 | Glucocorticoid antagonist | 0.124 0.004 DBMET00598 0.068 0.009 DBMET00605 | ||
| 0.349 | 0.002 | 0.349 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.06 0.007 DBMET00598 0.035 0.013 DBMET00605 | ||
| 0.344 | 0.001 | 0.344 | Na+ K+ transporting ATPase inhibitor | 0.17 0.004 DBMET00598 0.205 0.002 DBMET00605 | ||
| 0.389 | 0.048 | 0.389 | Caspase 3 stimulant | 0.212 0.153 DBMET00598 0.279 0.091 DBMET00605 | ||
| 0.344 | 0.007 | 0.344 | Cholesterol synthesis inhibitor | 0.183 0.031 DBMET00598 0.184 0.031 DBMET00605 | ||
| 0.38 | 0.056 | 0.554 | Immunostimulant | 0.539 0.024 DBMET00598 0.554 0.022 DBMET00605 | DBMET00605 | |
| 0.327 | 0.011 | 0.327 | Adenylate cyclase inhibitor | |||
| 0.332 | 0.018 | 0.382 | Melanin inhibitor | 0.382 0.013 DBMET00598 0.176 0.054 DBMET00605 | DBMET00598 | |
| 0.322 | 0.024 | 0.486 | Hepatoprotectant | 0.46 0.009 DBMET00598 0.486 0.008 DBMET00605 | DBMET00605 | |
| 0.304 | 0.006 | 0.304 | Estrogen antagonist | 0.134 0.034 DBMET00598 0.105 0.086 DBMET00605 | ||
| 0.295 | 0.001 | 0.295 | Anabolic | 0.148 0.019 DBMET00598 0.105 0.056 DBMET00605 | ||
| 0.326 | 0.036 | 0.363 | DNA synthesis inhibitor | 0.306 0.042 DBMET00598 0.363 0.028 DBMET00605 | DBMET00605 | |
| 0.322 | 0.041 | 0.689 | Angiogenesis stimulant | 0.689 0.005 DBMET00598 0.673 0.005 DBMET00605 | DBMET00598 | |
| 0.269 | 0.002 | 0.269 | 5-Alpha-reductase 2 inhibitor | |||
| 0.284 | 0.023 | 0.284 | Neurotrophic factor enhancer | 0.23 0.051 DBMET00598 0.284 0.023 DBMET00605 | ||
| 0.275 | 0.022 | 0.275 | Growth factor agonist | |||
| 0.247 | 0.002 | 0.247 | 5-Alpha-reductase 1 inhibitor | |||
| 0.249 | 0.006 | 0.249 | Estrogen agonist | 0.178 0.009 DBMET00598 0.112 0.015 DBMET00605 | ||
| 0.239 | 0.003 | 0.239 | RNA-directed RNA polymerase stimulant | 0.13 0.005 DBMET00598 0.091 0.007 DBMET00605 | ||
| 0.292 | 0.065 | 0.599 | Antioxidant | 0.599 0.011 DBMET00598 0.583 0.012 DBMET00605 | DBMET00598 | |
| 0.227 | 0.001 | 0.357 | Corticosteroid-like | 0.357 0.001 DBMET00598 0.343 0.001 DBMET00605 | DBMET00598 | |
| 0.234 | 0.014 | 0.234 | Farnesoid X receptor antagonist | 0.132 0.079 DBMET00598 0.161 0.042 DBMET00605 | ||
| 0.223 | 0.004 | 0.223 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.217 | 0.004 | 0.217 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.209 | 0.009 | 0.209 | Estrogen receptor beta antagonist | 0.1 0.065 DBMET00598 | ||
| 0.201 | 0.004 | 0.201 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.242 | 0.046 | 0.242 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.196 | 0.001 | 0.196 | Lipocortins synthesis agonist | 0.133 0.002 DBMET00598 0.121 0.003 DBMET00605 | ||
| 0.188 | 0.002 | 0.188 | Progesterone agonist | 0.064 0.004 DBMET00598 0.023 0.009 DBMET00605 | ||
| 0.217 | 0.032 | 0.282 | Interleukin 6 antagonist | 0.179 0.055 DBMET00598 0.282 0.017 DBMET00605 | DBMET00605 | |
| 0.218 | 0.034 | 0.218 | Phospholipase C inhibitor | 0.161 0.085 DBMET00605 | ||
| 0.295 | 0.113 | 0.295 | Toll-Like receptor 7 agonist | |||
| 0.191 | 0.012 | 0.191 | AMP-activated protein kinase stimulant | 0.12 0.049 DBMET00598 0.164 0.02 DBMET00605 | ||
| 0.197 | 0.02 | 0.197 | Microtubule formation inhibitor | 0.152 0.037 DBMET00598 0.147 0.039 DBMET00605 | ||
| 0.211 | 0.037 | 0.233 | Lipid peroxidase inhibitor | 0.233 0.03 DBMET00598 0.175 0.053 DBMET00605 | DBMET00598 | |
| 0.178 | 0.005 | 0.178 | Estrogen receptor beta agonist | 0.119 0.009 DBMET00598 0.04 0.021 DBMET00605 | ||
| 0.253 | 0.08 | 0.549 | Cardiotonic | 0.333 0.044 DBMET00598 0.549 0.011 DBMET00605 | DBMET00605 | |
| 0.287 | 0.119 | 0.287 | Toll-Like receptor agonist | |||
| 0.201 | 0.033 | 0.201 | Monophenol monooxygenase inhibitor | 0.135 0.053 DBMET00598 | ||
| 0.183 | 0.018 | 0.183 | Interleukin 8 antagonist | |||
| 0.238 | 0.087 | 0.238 | DNA damaging | 0.165 0.151 DBMET00598 | ||
| 0.156 | 0.005 | 0.156 | Estrogen receptor alpha agonist | 0.064 0.014 DBMET00598 | ||
| 0.154 | 0.006 | 0.169 | Glycine receptor agonist | 0.169 0.005 DBMET00598 0.146 0.007 DBMET00605 | DBMET00598 | |
| 0.172 | 0.025 | 0.172 | Pregnane X receptor agonist | |||
| 0.165 | 0.028 | 0.343 | Antineoplastic antibiotic | 0.269 0.012 DBMET00598 0.343 0.007 DBMET00605 | DBMET00605 | |
| 0.141 | 0.009 | 0.189 | Glycine receptor antagonist | 0.168 0.005 DBMET00598 0.189 0.004 DBMET00605 | DBMET00605 | |
| 0.169 | 0.04 | 0.183 | DNA polymerase I inhibitor | 0.183 0.034 DBMET00598 0.164 0.042 DBMET00605 | DBMET00598 | |
| 0.137 | 0.015 | 0.137 | Interleukin 5 antagonist | 0.081 0.072 DBMET00598 | ||
| 0.151 | 0.035 | 0.151 | GABA receptor agonist | |||
| 0.119 | 0.004 | 0.119 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.157 | 0.043 | 0.244 | Alkylator | 0.244 0.017 DBMET00598 0.224 0.02 DBMET00605 | DBMET00598 | |
| 0.116 | 0.004 | 0.116 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.161 | 0.05 | 0.243 | Neurotrophic factor | 0.202 0.027 DBMET00598 0.243 0.013 DBMET00605 | DBMET00605 | |
| 0.203 | 0.092 | 0.252 | Hypolipemic | 0.187 0.104 DBMET00598 0.252 0.066 DBMET00605 | DBMET00605 | |
| 0.121 | 0.019 | 0.121 | Bile acid receptor antagonist | 0.089 0.077 DBMET00605 | ||
| 0.105 | 0.003 | 0.105 | Pregnane X receptor antagonist | |||
| 0.117 | 0.026 | 0.117 | GABA A receptor agonist | |||
| 0.197 | 0.112 | 0.252 | Tumour necrosis factor alpha release inhibitor | 0.246 0.077 DBMET00598 0.252 0.074 DBMET00605 | DBMET00605 | |
| 0.085 | 0.018 | 0.085 | Nitric oxide donor | 0.064 0.041 DBMET00598 0.064 0.042 DBMET00605 | ||
| 0.176 | 0.118 | 0.417 | Free radical scavenger | 0.417 0.026 DBMET00598 0.372 0.034 DBMET00605 | DBMET00598 | |
| 0.064 | 0.006 | 0.064 | Estrone sulfatase inhibitor | |||
| 0.098 | 0.04 | 0.188 | Topoisomerase II alpha inhibitor | 0.188 0.017 DBMET00598 0.181 0.018 DBMET00605 | DBMET00598 | |
| 0.102 | 0.047 | 0.102 | ABCA1 expression enhancer | |||
| 0.074 | 0.02 | 0.074 | Heme oxygenase stimulant | |||
| 0.129 | 0.084 | 0.135 | Protein kinase stimulant | 0.112 0.102 DBMET00598 0.135 0.079 DBMET00605 | DBMET00605 | |
| 0.091 | 0.05 | 0.17 | Transcription factor NF kappa B stimulant | 0.113 0.029 DBMET00598 0.17 0.012 DBMET00605 | DBMET00605 | |
| 0.047 | 0.007 | 0.047 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.059 | 0.021 | 0.059 | Adenosine deaminase inhibitor | |||
| 0.118 | 0.083 | 0.51 | Amylase inhibitor | 0.51 0.005 DBMET00598 0.318 0.016 DBMET00605 | DBMET00598 | |
| 0.055 | 0.021 | 0.055 | Microtubule stabilization | 0.05 0.028 DBMET00598 0.049 0.029 DBMET00605 | ||
| 0.069 | 0.036 | 0.069 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.15 | 0.118 | 0.15 | Interleukin antagonist | |||
| 0.033 | 0.008 | 0.033 | Hedgehog signaling activator | |||
| 0.084 | 0.061 | 0.109 | Antineoplastic alkaloid | 0.079 0.066 DBMET00598 0.109 0.042 DBMET00605 | DBMET00605 | |
| 0.022 | 0.003 | 0.022 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 DBMET00598 | ||
| 0.127 | 0.109 | 0.127 | Adenylate cyclase stimulant | |||
| 0.07 | 0.056 | 0.07 | CDC25A inhibitor | 0.066 0.064 DBMET00605 | ||
| 0.038 | 0.025 | 0.038 | Farnesoid X receptor agonist | |||
| 0.109 | 0.097 | 0.109 | Bone formation stimulant | |||
| 0.022 | 0.014 | 0.022 | Vitamin D receptor antagonist | 0.021 0.019 DBMET00598 | ||
| 0.015 | 0.01 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.017 | 0.013 | 0.021 | Telomerase stimulant | 0.017 0.012 DBMET00598 0.021 0.007 DBMET00605 | DBMET00605 | |
| 0.09 | 0.089 | 0.183 | Toll-Like receptor 4 antagonist | 0.183 0.009 DBMET00598 0.137 0.029 DBMET00605 | DBMET00598 | |
| 0.161 | 0.16 | 0.414 | Hypoglycemic | 0.414 0.025 DBMET00598 0.414 0.025 DBMET00605 | DBMET00605 | |
| 0.069 | 0.068 | 0.069 | Keratolytic | |||
| 0.156 | 0.158 | 0.32 | Spasmolytic | 0.243 0.094 DBMET00598 0.32 0.063 DBMET00605 | DBMET00605 | |
| 0.086 | 0.087 | 0.319 | Expectorant | 0.14 0.04 DBMET00598 0.319 0.007 DBMET00605 | DBMET00605 | |
| 0.016 | 0.04 | 0.045 | Protein 30S ribosomal subunit inhibitor | 0.04 0.01 DBMET00598 0.045 0.009 DBMET00605 | DBMET00605 | |
| 0.199 | 0.23 | 0.626 | Antibacterial | 0.59 0.021 DBMET00598 0.626 0.016 DBMET00605 | DBMET00605 | |
| 0.081 | 0.112 | 0.142 | Mucolytic | 0.142 0.037 DBMET00605 | DBMET00605 | |
| 0.124 | 0.159 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 DBMET00598 0.151 0.041 DBMET00605 | DBMET00605 | |
| 0.076 | 0.115 | 0.267 | Topoisomerase II inhibitor | 0.255 0.024 DBMET00598 0.267 0.022 DBMET00605 | DBMET00605 | |
| 0.128 | 0.186 | 0.405 | Interleukin agonist | 0.323 0.038 DBMET00598 0.405 0.018 DBMET00605 | DBMET00605 | |
| 0.072 | 0.134 | 0.139 | Beta glucuronidase inhibitor | 0.139 0.03 DBMET00598 0.094 0.08 DBMET00605 | DBMET00598 | |
| 0.156 | 0.225 | 0.429 | Immunomodulator | 0.429 0.036 DBMET00598 0.397 0.045 DBMET00605 | DBMET00598 | |
| 0.026 | 0.1 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.075 0.021 DBMET00598 0.093 0.015 DBMET00605 | DBMET00605 | |
| 0.033 | 0.109 | 0.062 | Glucose-6-phosphate translocase inhibitor | 0.055 0.031 DBMET00598 0.062 0.022 DBMET00605 | DBMET00605 | |
| 0.004 | 0.083 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET00605 | DBMET00605 | |
| 0.058 | 0.138 | 0.12 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.063 DBMET00605 | DBMET00605 | |
| 0.022 | 0.105 | 0.071 | Antibiotic Aminoglycoside-like | 0.064 0.007 DBMET00598 0.071 0.006 DBMET00605 | DBMET00605 | |
| 0.012 | 0.117 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET00605 | DBMET00605 | |
| 0.054 | 0.161 | 0.106 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 DBMET00598 0.094 0.068 DBMET00605 | DBMET00598 | |
| 0.088 | 0.205 | 0.366 | Platelet adhesion inhibitor | 0.329 0.025 DBMET00598 0.366 0.016 DBMET00605 | DBMET00605 | |
| 0.132 | 0.255 | 0.351 | Peptidyltransferase inhibitor | 0.319 0.019 DBMET00598 0.351 0.012 DBMET00605 | DBMET00605 | |
| 0.05 | 0.176 | 0.153 | DNA intercalator | 0.153 0.041 DBMET00598 0.138 0.048 DBMET00605 | DBMET00598 | |
| 0.134 | 0.278 | 0.552 | Antithrombotic | 0.481 0.032 DBMET00598 0.552 0.022 DBMET00605 | DBMET00605 | |
| 0.021 | 0.174 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET00605 | DBMET00605 | |
| 0.059 | 0.222 | 0.081 | T cell inhibitor | 0.081 0.062 DBMET00598 0.079 0.07 DBMET00605 | DBMET00598 | |
| 0.033 | 0.211 | 0.192 | Topoisomerase I inhibitor | 0.192 0.028 DBMET00598 0.177 0.032 DBMET00605 | DBMET00598 | |
| 0.012 | 0.225 | 0.048 | Mannosidase inhibitor | 0.048 0.028 DBMET00605 | DBMET00605 | |
| 0.07 | 0.302 | 0.325 | Insulin secretagoues | 0.244 0.021 DBMET00598 0.325 0.01 DBMET00605 | DBMET00605 | |
| 0.049 | 0.293 | 0.211 | Cyclooxygenase 3 inhibitor | 0.177 0.029 DBMET00598 0.211 0.015 DBMET00605 | DBMET00605 | |
| 0.013 | 0.289 | 0.276 | Selectin antagonist | 0.209 0.01 DBMET00598 0.276 0.007 DBMET00605 | DBMET00605 | |
| 0.013 | 0.339 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET00598 0.028 0.014 DBMET00605 | DBMET00598 | |
| 0.03 | 0.364 | 0.192 | Thrombolytic | 0.157 0.076 DBMET00598 0.192 0.056 DBMET00605 | DBMET00605 | |
| 0.052 | 0.397 | 0.236 | Vasodilator | 0.21 0.097 DBMET00598 0.236 0.078 DBMET00605 | DBMET00605 | |
| 0.084 | 0.486 | 0.123 | CC chemokine 6 receptor antagonist | 0.12 0.116 DBMET00598 0.123 0.1 DBMET00605 | DBMET00605 | |
| 0.029 | 0.486 | 0.116 | Cell adhesion inhibitor | 0.099 0.091 DBMET00598 0.116 0.068 DBMET00605 | DBMET00605 | |
| 0.012 | 0.524 | 0.085 | Heparanase inhibitor | 0.085 0.005 DBMET00605 | DBMET00605 | |
| 0.02 | 0.583 | 0.176 | Platelet antagonist | 0.176 0.12 DBMET00605 | DBMET00605 | |
| 0.017 | 0.687 | 0.126 | Hemostatic | 0.126 0.103 DBMET00605 | DBMET00605 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |